ES2076320T3 - Adyuvante angiografico. - Google Patents
Adyuvante angiografico.Info
- Publication number
- ES2076320T3 ES2076320T3 ES90307268T ES90307268T ES2076320T3 ES 2076320 T3 ES2076320 T3 ES 2076320T3 ES 90307268 T ES90307268 T ES 90307268T ES 90307268 T ES90307268 T ES 90307268T ES 2076320 T3 ES2076320 T3 ES 2076320T3
- Authority
- ES
- Spain
- Prior art keywords
- angiographic
- adjuvant
- angiographic adjuvant
- prostaglandins
- clarity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002671 adjuvant Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002960 lipid emulsion Substances 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
UN ADYUVANTE ANGIOGRAFICO COMPRENDE UNA EMULSION GRASA QUE CONTIENE UN COMPUESTO QUE TIENE PROSTAGLANDINAS E1 ACTIVAS. EN UN METODO ANGIOGRAFICO, EL ADYUVANTE MEJORA LA CLARIDAD DE LOS GRAFICOS RESULTANTES
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1173709A JPH0669966B2 (ja) | 1989-07-05 | 1989-07-05 | 血管造影補助剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2076320T3 true ES2076320T3 (es) | 1995-11-01 |
Family
ID=15965683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90307268T Expired - Lifetime ES2076320T3 (es) | 1989-07-05 | 1990-07-03 | Adyuvante angiografico. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5445812A (es) |
EP (1) | EP0407148B1 (es) |
JP (1) | JPH0669966B2 (es) |
KR (1) | KR0160127B1 (es) |
CA (1) | CA2020368C (es) |
DE (1) | DE69021289T2 (es) |
DK (1) | DK0407148T3 (es) |
ES (1) | ES2076320T3 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4135193C1 (es) * | 1991-10-22 | 1993-03-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
US5807895A (en) * | 1994-11-29 | 1998-09-15 | Schwarz Pharma, Inc. | Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents |
WO1996016661A2 (en) * | 1994-11-29 | 1996-06-06 | Schwarz Pharma, Inc. | Use of prostaglandin e1, e2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents |
DE4446694A1 (de) * | 1994-12-09 | 1996-06-13 | Schering Ag | Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung |
US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
US6011062A (en) * | 1994-12-22 | 2000-01-04 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
US6054421A (en) * | 1997-09-23 | 2000-04-25 | Scimed Life Systems, Inc. | Medical emulsion lubricant |
US6281175B1 (en) | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
US6246897B1 (en) | 1998-12-11 | 2001-06-12 | General Electric Company | Method and system for acquistion of preferential arterial and venous images for MR angiography |
US6192264B1 (en) | 1998-12-28 | 2001-02-20 | General Electric Company | Method and system for MRI venography including arterial and venous discrimination |
US20080132797A1 (en) * | 2002-12-10 | 2008-06-05 | Knut Brabrand | Monitoring infusion of a substance |
AT518009A1 (de) * | 2015-07-27 | 2017-06-15 | Gebro Holding Gmbh | Konzentrat enthaltend Alprostadil |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58222014A (ja) * | 1982-06-18 | 1983-12-23 | Taisho Pharmaceut Co Ltd | プロスタグランジンe↓1脂肪乳剤 |
JPS59206349A (ja) * | 1983-05-10 | 1984-11-22 | Green Cross Corp:The | プロスタグランジンe↓1誘導体 |
JPS59216820A (ja) * | 1983-05-20 | 1984-12-06 | Taisho Pharmaceut Co Ltd | プロスタグランジン脂肪乳剤 |
JPH0818989B2 (ja) * | 1984-01-12 | 1996-02-28 | 株式会社ミドリ十字 | 脂肪乳剤中のプロスタグランジンの安定化方法 |
DE3421468A1 (de) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
JPS61289034A (ja) * | 1985-06-17 | 1986-12-19 | Teijin Ltd | イソカルバサイクリン類脂肪乳剤 |
US4820732A (en) * | 1985-10-04 | 1989-04-11 | The Upjohn Company | Method and compositions for reducing dysfunction in angioplasty procedures |
US4955878A (en) * | 1986-04-04 | 1990-09-11 | Biotechnology, Inc. | Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures |
US5120527A (en) * | 1989-10-19 | 1992-06-09 | King Chuen Peter Li | Paramagnetic oil emulsions as mri contrast agents |
US5064636A (en) * | 1989-10-19 | 1991-11-12 | Li King C P | Paramagnetic oil emulsions as enteric MRI contrast agents |
-
1989
- 1989-07-05 JP JP1173709A patent/JPH0669966B2/ja not_active Expired - Lifetime
-
1990
- 1990-07-03 DK DK90307268.4T patent/DK0407148T3/da active
- 1990-07-03 DE DE69021289T patent/DE69021289T2/de not_active Expired - Fee Related
- 1990-07-03 ES ES90307268T patent/ES2076320T3/es not_active Expired - Lifetime
- 1990-07-03 EP EP90307268A patent/EP0407148B1/en not_active Expired - Lifetime
- 1990-07-04 CA CA002020368A patent/CA2020368C/en not_active Expired - Fee Related
- 1990-07-05 KR KR1019900010174A patent/KR0160127B1/ko not_active IP Right Cessation
-
1994
- 1994-10-19 US US08/325,648 patent/US5445812A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2020368A1 (en) | 1991-01-06 |
DE69021289T2 (de) | 1996-03-21 |
DE69021289D1 (de) | 1995-09-07 |
EP0407148A2 (en) | 1991-01-09 |
KR910002470A (ko) | 1991-02-25 |
EP0407148A3 (en) | 1992-01-08 |
CA2020368C (en) | 2001-09-11 |
JPH0466540A (ja) | 1992-03-02 |
DK0407148T3 (da) | 1995-09-18 |
EP0407148B1 (en) | 1995-08-02 |
KR0160127B1 (ko) | 1998-12-01 |
JPH0669966B2 (ja) | 1994-09-07 |
US5445812A (en) | 1995-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2076320T3 (es) | Adyuvante angiografico. | |
ES518582A0 (es) | Un procedimiento para preparar una composicion farmaceutica acuosa que contiene ubidecarenona. | |
MX9101734A (es) | Dispositivo para implantarse en un huesped,que forma estructuras y vasculares en la interfase entre al menos una porcion de dicho dispositivo y el huesped y metodo para implantar dicho dispositivo | |
ES2052495T3 (es) | Terapia de fluidos con aniones l-lactato y/o piruvato. | |
ES2159037T3 (es) | Sistema de comunicaciones diferenciador. | |
IT8224518A0 (it) | Dispositivo limitatore di pressione frangibile. | |
ES2082158T3 (es) | Alojamiento para conjuntos de conexion. | |
IT8423398A0 (it) | Supporto per un albero nel foro di una cassa. | |
NL7701654A (nl) | Axiale zuigerpomp. | |
CO4230148A1 (es) | Metodo para referenciar datos sismicos mediante modelado a- vanzado | |
ES2038444T3 (es) | Metodo de piscicultura. | |
ES2038064B1 (es) | Instalacion portatil de vacunacion aviar. | |
ES519562A0 (es) | Una bomba que incluye un anillo excentrico. | |
NO893412L (no) | Kretskortpakke som taaler meget hoey akselerasjon. | |
IT1225435B (it) | Apparecchiatura per controllare la condizione operativa di una valvola di non ritorno. | |
IT8322218A0 (it) | Analoghi della vitamina d. | |
FI894072A0 (fi) | Polypeptider anvaendbara som vaccin. | |
MX16291A (es) | Compuestos triyodobencenicos, no ionicos, yodados, y productos de contraste que los contienen. | |
DE3771065D1 (de) | Kolbenmembranpumpe. | |
ES2058601T3 (es) | Formulaciones que contienen heparina. | |
ES2050655T3 (es) | Aguja quirurgica oscura. | |
JPS52113692A (en) | Solid laser element supporting device | |
IT8467928A1 (it) | Dispositivo per la trasmissione di linguaggio. | |
MX168135B (es) | Metodo de procesamiento de caracteres compuestos procesadores de palabras | |
SU605974A2 (ru) | Способ образовани лед ной облицовки подземного сооружени |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 407148 Country of ref document: ES |